SCHEMBL6164522

SCHEMBL6164522

CC1(C)CCc2c(c([C@@H]3C[C@H]3c3ccccc3)nn2CC(F)(F)F)C1=O

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.33
KDM1A O60341 1/20 0.33
BACE1 P56817 1/20 0.32
POLQ O75417 2/20 0.32
PTGS2 P35354 1/20 0.31
NTRK1 P04629 1/20 0.31
MCL1 Q07820 1/20 0.31
RIPK1 Q13546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164521 1.00 TACR1 (0.33) TACR1KDM1ABACE1POLQPTGS2
SCHEMBL6166383 0.84 KDM1A (0.34) TACR1KDM1ABACE1POLQRIPK1
SCHEMBL6166381 0.84 KDM1A (0.34) TACR1KDM1ABACE1POLQRIPK1
SCHEMBL6163503 0.79 PTGS2 (0.40) POLQPTGS2
SCHEMBL6163459 0.74 HDAC9 (0.35) POLQPTGS2
SCHEMBL6164181 0.73 CCNA2 (0.40)
SCHEMBL6164177 0.73 CCNA2 (0.40)
SCHEMBL6164936 0.72 CDC7 (0.39) PTGS2
SCHEMBL6165976 0.72 ADORA1 (0.38)
SCHEMBL6167776 0.71 AURKA (0.31) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed